KR100532647B1 - 진통제 배합물 - Google Patents

진통제 배합물 Download PDF

Info

Publication number
KR100532647B1
KR100532647B1 KR10-1999-7009433A KR19997009433A KR100532647B1 KR 100532647 B1 KR100532647 B1 KR 100532647B1 KR 19997009433 A KR19997009433 A KR 19997009433A KR 100532647 B1 KR100532647 B1 KR 100532647B1
Authority
KR
South Korea
Prior art keywords
component
action
coated
minutes
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-1999-7009433A
Other languages
English (en)
Korean (ko)
Other versions
KR20010006348A (ko
Inventor
디이터 노이저
모니카 피루스
볼프강 비이흘
Original Assignee
바이엘 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 악티엔게젤샤프트 filed Critical 바이엘 악티엔게젤샤프트
Publication of KR20010006348A publication Critical patent/KR20010006348A/ko
Application granted granted Critical
Publication of KR100532647B1 publication Critical patent/KR100532647B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR10-1999-7009433A 1997-04-15 1998-04-02 진통제 배합물 Expired - Fee Related KR100532647B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19715594A DE19715594A1 (de) 1997-04-15 1997-04-15 Analgetika-Kombination
DE19715594.4 1997-04-15
PCT/EP1998/001926 WO1998046235A1 (de) 1997-04-15 1998-04-02 Analgetika-kombination

Publications (2)

Publication Number Publication Date
KR20010006348A KR20010006348A (ko) 2001-01-26
KR100532647B1 true KR100532647B1 (ko) 2005-12-02

Family

ID=7826504

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-1999-7009433A Expired - Fee Related KR100532647B1 (ko) 1997-04-15 1998-04-02 진통제 배합물

Country Status (23)

Country Link
US (1) US6929805B2 (enExample)
EP (1) EP0979087B1 (enExample)
JP (1) JP2002503221A (enExample)
KR (1) KR100532647B1 (enExample)
CN (1) CN1177589C (enExample)
AR (1) AR012417A1 (enExample)
AT (1) ATE253919T1 (enExample)
AU (1) AU742622B2 (enExample)
BR (1) BR9808875A (enExample)
CA (1) CA2285979C (enExample)
DE (2) DE19715594A1 (enExample)
DK (1) DK0979087T3 (enExample)
ES (1) ES2210754T3 (enExample)
HU (1) HU225601B1 (enExample)
NO (1) NO323022B1 (enExample)
NZ (1) NZ500262A (enExample)
PL (1) PL190863B1 (enExample)
PT (1) PT979087E (enExample)
RS (1) RS49620B (enExample)
RU (1) RU2218180C2 (enExample)
TR (1) TR199902396T2 (enExample)
WO (1) WO1998046235A1 (enExample)
YU (1) YU52999A (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
AU1713501A (en) * 1999-11-23 2001-06-04 Robert Gordon University, The Bilayered buccal tablets comprising nicotine
WO2001045678A2 (de) * 1999-12-21 2001-06-28 Id Pharma Gmbh Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
KR20010069756A (ko) * 2001-05-08 2001-07-25 유형선 소염진통제인 아세메타신을 함유하며 장관내 특히대장에서의 약물 방출 속도가 조절되는 약물 전달 체계에대한 약제학적 경구용 조성물 및 그에 대한 제조방법
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
DE102004001093A1 (de) * 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
DE102004040630A1 (de) * 2004-08-21 2006-03-09 Balaban, Romulus, Dr.med. Kombinationstherapie mit Procain
RU2283112C1 (ru) * 2005-10-04 2006-09-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Противовоспалительное лекарственное средство
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
DE102008007212B3 (de) 2008-02-01 2009-10-15 BSH Bosch und Siemens Hausgeräte GmbH Gehäuse für den Antrieb eines elektrischen Geräts, insbesondere eines Haushaltsgeräts
US8905980B2 (en) 2008-08-01 2014-12-09 Tian Xia Devices for delivering a medicament and methods for ameliorating pain
US8690839B2 (en) 2008-08-01 2014-04-08 Tian Xia Devices for delivering a medicament and connector for same
US8231588B2 (en) * 2008-08-01 2012-07-31 Tian Xia Methods for ameliorating pain and devices for delivering a medicament
US20130049932A1 (en) * 2011-08-25 2013-02-28 Elwha LLC, a limited liability company of the State of Delaware Systems, devices, methods, and admixtures of transponders and food products for indication of food attributes
US10016580B2 (en) 2013-12-17 2018-07-10 Biovision Technologies, Llc Methods for treating sinus diseases
US9510743B2 (en) 2013-12-17 2016-12-06 Biovision Technologies, Llc Stabilized surgical device for performing a sphenopalatine ganglion block procedure
US9516995B2 (en) 2013-12-17 2016-12-13 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
US9694163B2 (en) 2013-12-17 2017-07-04 Biovision Technologies, Llc Surgical device for performing a sphenopalatine ganglion block procedure
DE102015114799A1 (de) * 2015-09-04 2017-03-09 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Druckmittelaggregat, mit einem durch Spritzgießen hergestellten Gehäuse aus Kunststoff sowie Verfahren zu seiner Herstellung
WO2019064090A1 (en) * 2017-09-28 2019-04-04 Zenvision Pharma Llp NOVEL PHARMACEUTICAL COMPOSITION COMPRISING MEFENAMIC ACID AND OTHER ANALGESICS
US10525240B1 (en) 2018-06-28 2020-01-07 Sandler Scientific LLC Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system
WO2025170507A1 (en) * 2024-02-07 2025-08-14 Oncozenge Ab A lozenge

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026502A (en) * 1961-10-13 1966-04-20 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
DE3328401A1 (de) 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
US4851233A (en) * 1986-10-06 1989-07-25 Warner-Lambert Company Sustained release formulations
US5064858A (en) 1988-08-17 1991-11-12 Spectrum Pharmaceutical Corporation Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and Alzheimer's disease
IL95423A (en) 1989-09-21 1994-11-11 American Cyanamid Co Pulsatile once-a-day delivery systems for minocycline
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
IT1242642B (it) 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
GB9121204D0 (en) 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
NZ253999A (en) * 1992-08-05 1996-07-26 Faulding F H & Co Ltd Pelletised substained release medicament
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US5451409A (en) 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5702723A (en) * 1994-08-02 1997-12-30 Griffin; David Multi-stage delivery system for ingestible medications or nutrients
TW483763B (en) 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
AU4988696A (en) * 1995-03-29 1996-10-16 Procter & Gamble Company, The Antitussive microcapsules

Also Published As

Publication number Publication date
CN1252725A (zh) 2000-05-10
RS49620B (sr) 2007-08-03
DK0979087T3 (da) 2004-03-08
JP2002503221A (ja) 2002-01-29
HK1027505A1 (en) 2001-01-19
CA2285979A1 (en) 1998-10-22
CA2285979C (en) 2009-11-24
PL190863B1 (pl) 2006-02-28
HU225601B1 (en) 2007-05-02
WO1998046235A1 (de) 1998-10-22
BR9808875A (pt) 2000-07-11
NZ500262A (en) 2002-04-26
US6929805B2 (en) 2005-08-16
US20010002999A1 (en) 2001-06-07
NO994663L (no) 1999-09-24
NO994663D0 (no) 1999-09-24
ATE253919T1 (de) 2003-11-15
EP0979087A1 (de) 2000-02-16
TR199902396T2 (xx) 2000-01-21
HUP0003636A2 (hu) 2001-05-28
CN1177589C (zh) 2004-12-01
AR012417A1 (es) 2000-10-18
HUP0003636A3 (en) 2001-12-28
DE19715594A1 (de) 1998-10-22
NO323022B1 (no) 2006-12-27
KR20010006348A (ko) 2001-01-26
YU52999A (sh) 2002-06-19
DE59810166D1 (de) 2003-12-18
PT979087E (pt) 2004-03-31
ES2210754T3 (es) 2004-07-01
PL336154A1 (en) 2000-06-05
AU742622B2 (en) 2002-01-10
RU2218180C2 (ru) 2003-12-10
EP0979087B1 (de) 2003-11-12
AU7428698A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
KR100532647B1 (ko) 진통제 배합물
US6166083A (en) Suckable flurbiprofen lozenges for treatment of sore throat
CA2087723C (en) Treatment with flurbiprofen of pain and inflammation in mammals
US6368618B1 (en) Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
PT96550A (pt) Processo para a libertacao percutanea de ibuprofeno utilizando gel hidro-alcoolico
KR19980064024A (ko) 약학 조성물
MXPA02003312A (es) Composiciones que tienen estabilidad mejorada.
JPS60208913A (ja) 高めた無痛覚を与える製薬製品
WO1998052540A1 (en) Pharmaceutical compositions
WO2003089007A1 (en) Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
PL190733B1 (pl) Zastosowanie przeciwmigrenowej kombinacji i kompozycja farmaceutyczna do leczenia migreny
JPH0141608B2 (enExample)
JPH08506808A (ja) 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
DE4319438C1 (de) Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
PL168968B1 (en) Method of manufacturing an antitussive drug
MXPA99009225A (en) Analgesic combination
HK1027505B (en) Analgesic combination
JP2764261B2 (ja) 外用消炎鎮痛剤
JP2004339211A5 (enExample)
JP2004331660A5 (enExample)
JP7229012B2 (ja) 内服用医薬組成物
JP7229013B2 (ja) 内服用医薬組成物
KR20240029152A (ko) 가려움증 치료제에 쓰일 수 있는 프로피온산계 비스테로이드성 약물을 유효성분으로 함유하는 외용 겔 제제의 제조법
WO1994009767A1 (en) Novel use of pharmaceutical compositions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20081110

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20091125

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20091125

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000